Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 46

2.

Viral Specific Factors Contribute to Clinical Respiratory Syncytial Virus Disease Severity Differences in Infants.

Thompson TM, Roddam PL, Harrison LM, Aitken JA, DeVincenzo JP.

Clin Microbiol. 2015 Jun;4(3). pii: 206. Epub 2015 Jun 29.

3.

Vitamin D Levels Are Unrelated to the Severity of Respiratory Syncytial Virus Bronchiolitis Among Hospitalized Infants.

Beigelman A, Castro M, Schweiger TL, Wilson BS, Zheng J, Yin-DeClue H, Sajol G, Giri T, Sierra OL, Isaacson-Schmid M, Sumino K, Schechtman KB, Bacharier LB.

J Pediatric Infect Dis Soc. 2015 Sep;4(3):182-8. doi: 10.1093/jpids/piu042. Epub 2014 Jun 5.

PMID:
26336601
4.

Risk of urinary tract infection in infants and children with acute bronchiolitis.

Hendaus MA, Alhammadi AH, Khalifa MS, Muneer E, Chandra P.

Paediatr Child Health. 2015 Jun-Jul;20(5):e25-9.

5.

Biomarkers of respiratory syncytial virus (RSV) infection: specific neutrophil and cytokine levels provide increased accuracy in predicting disease severity.

Brown PM, Schneeberger DL, Piedimonte G.

Paediatr Respir Rev. 2015 Sep;16(4):232-40. doi: 10.1016/j.prrv.2015.05.005. Epub 2015 May 23. Review.

PMID:
26074450
6.

Bordetella pertussis is an uncommon pathogen in children hospitalized with bronchiolitis during the winter season.

Piedra PA, Mansbach JM, Jewell AM, Thakar SD, Grant CC, Sullivan AF, Espinola JA, Camargo CA Jr.

Pediatr Infect Dis J. 2015 Jun;34(6):566-70. doi: 10.1097/INF.0000000000000596.

7.

Randomized trial to evaluate azithromycin's effects on serum and upper airway IL-8 levels and recurrent wheezing in infants with respiratory syncytial virus bronchiolitis.

Beigelman A, Isaacson-Schmid M, Sajol G, Baty J, Rodriguez OM, Leege E, Lyons K, Schweiger TL, Zheng J, Schechtman KB, Castro M, Bacharier LB.

J Allergy Clin Immunol. 2015 May;135(5):1171-8.e1. doi: 10.1016/j.jaci.2014.10.001. Epub 2014 Nov 18.

8.

Perinatal and early childhood environmental factors influencing allergic asthma immunopathogenesis.

Gaffin JM, Kanchongkittiphon W, Phipatanakul W.

Int Immunopharmacol. 2014 Sep;22(1):21-30. doi: 10.1016/j.intimp.2014.06.005. Epub 2014 Jun 19. Review.

9.

Highly sulfated K5 Escherichia coli polysaccharide derivatives inhibit respiratory syncytial virus infectivity in cell lines and human tracheal-bronchial histocultures.

Cagno V, Donalisio M, Civra A, Volante M, Veccelli E, Oreste P, Rusnati M, Lembo D.

Antimicrob Agents Chemother. 2014 Aug;58(8):4782-94. doi: 10.1128/AAC.02594-14. Epub 2014 Jun 9.

10.

Respiratory syncytial virus surveillance in the United States, 2007-2012: results from a national surveillance system.

McGuiness CB, Boron ML, Saunders B, Edelman L, Kumar VR, Rabon-Stith KM.

Pediatr Infect Dis J. 2014 Jun;33(6):589-94. doi: 10.1097/INF.0000000000000257.

11.

Is the interpretation of rapid antigen testing for respiratory syncytial virus as simple as positive or negative?

Walsh P, Overmyer C, Hancock C, Heffner J, Walker N, Nguyen T, Shanholtzer L, Caldera E, Pusavat J, Mordechai E, Adelson ME, Iacono KT.

Emerg Med J. 2014 Feb;31(2):153-9. doi: 10.1136/emermed-2013-202729. Epub 2013 Aug 20.

12.

Association of RSV-related hospitalization and non-compliance with palivizumab among commercially insured infants: a retrospective claims analysis.

Stewart DL, Ryan KJ, Seare JG, Pinsky B, Becker L, Frogel M.

BMC Infect Dis. 2013 Jul 19;13:334. doi: 10.1186/1471-2334-13-334.

13.

Trends in bronchiolitis hospitalizations in the United States, 2000-2009.

Hasegawa K, Tsugawa Y, Brown DF, Mansbach JM, Camargo CA Jr.

Pediatrics. 2013 Jul;132(1):28-36. doi: 10.1542/peds.2012-3877. Epub 2013 Jun 3.

14.

National survey of pediatric services available in US emergency departments.

Sullivan AF, Rudders SA, Gonsalves AL, Steptoe AP, Espinola JA, Camargo CA Jr.

Int J Emerg Med. 2013 Apr 24;6(1):13. doi: 10.1186/1865-1380-6-13.

15.

Infant baboons infected with respiratory syncytial virus develop clinical and pathological changes that parallel those of human infants.

Papin JF, Wolf RF, Kosanke SD, Jenkins JD, Moore SN, Anderson MP, Welliver RC Sr.

Am J Physiol Lung Cell Mol Physiol. 2013 Apr 15;304(8):L530-9. doi: 10.1152/ajplung.00173.2012. Epub 2013 Feb 15.

16.

Antioxidant mimetics modulate oxidative stress and cellular signaling in airway epithelial cells infected with respiratory syncytial virus.

Hosakote YM, Komaravelli N, Mautemps N, Liu T, Garofalo RP, Casola A.

Am J Physiol Lung Cell Mol Physiol. 2012 Dec 1;303(11):L991-1000. doi: 10.1152/ajplung.00192.2012. Epub 2012 Sep 28.

17.

Inhibition of human respiratory syncytial virus infectivity by a dendrimeric heparan sulfate-binding peptide.

Donalisio M, Rusnati M, Cagno V, Civra A, Bugatti A, Giuliani A, Pirri G, Volante M, Papotti M, Landolfo S, Lembo D.

Antimicrob Agents Chemother. 2012 Oct;56(10):5278-88. doi: 10.1128/AAC.00771-12. Epub 2012 Jul 30.

18.

Determinants of asthma after severe respiratory syncytial virus bronchiolitis.

Bacharier LB, Cohen R, Schweiger T, Yin-Declue H, Christie C, Zheng J, Schechtman KB, Strunk RC, Castro M.

J Allergy Clin Immunol. 2012 Jul;130(1):91-100.e3. doi: 10.1016/j.jaci.2012.02.010. Epub 2012 Mar 22.

19.

Respiratory syncytial virus load, viral dynamics, and disease severity in previously healthy naturally infected children.

El Saleeby CM, Bush AJ, Harrison LM, Aitken JA, Devincenzo JP.

J Infect Dis. 2011 Oct 1;204(7):996-1002. doi: 10.1093/infdis/jir494.

20.

Household tobacco smoke and admission weight predict severe bronchiolitis in infants independent of deprivation: prospective cohort study.

Semple MG, Taylor-Robinson DC, Lane S, Smyth RL.

PLoS One. 2011;6(7):e22425. doi: 10.1371/journal.pone.0022425. Epub 2011 Jul 19.

Items per page

Supplemental Content

Write to the Help Desk